Topic

New Jersey

A collection of 505 issues

How to Get Prolastin-C Covered by Cigna in New Jersey: Appeals, Forms & Alternative Options

Quick Answer: Getting Prolastin-C Covered by Cigna in New Jersey Eligibility: Adults with severe alpha-1 antitrypsin deficiency (serum level <11 mcM/<80 mg/dL) and emphysema. Fastest path: Submit prior authorization with pulmonologist's medical necessity letter including genotype, lung function tests, and smoking cessation documentation. First

How to Get Bylvay (odevixibat) Covered by Aetna (CVS Health) in New Jersey: Complete Timeline and Appeals Guide

Answer Box: Getting Bylvay Covered by Aetna in New Jersey Aetna (CVS Health) requires prior authorization for Bylvay (odevixibat) with approval typically within 24 hours for complete commercial plan submissions. Key requirements: specialist prescription, genetic diagnosis confirmation (PFIC or Alagille syndrome), documented prior therapy failures, and baseline labs. If denied,

Work With Your Doctor to Get Ofev (Nintedanib) Covered by Humana in New Jersey: Complete Guide

Answer Box: Get Ofev (Nintedanib) Covered by Humana in New Jersey Ofev requires prior authorization from Humana Medicare Advantage plans. Success depends on your pulmonologist providing specific documentation: confirmed IPF diagnosis via HRCT, recent PFTs showing FVC ≥40% predicted, and a detailed medical necessity letter. If denied, you have 65

Amondys 45 (Casimersen) Approval with Aetna (CVS Health) in New Jersey: Complete Guide to Prior Authorization, Appeals, and Coverage Requirements

Quick Answer: Getting Amondys 45 (Casimersen) Covered by Aetna (CVS Health) in New Jersey Eligibility: DMD patients with exon 45-amenable mutations, under 14 at treatment start, able to walk ≥300 meters independently, prescribed by a neuromuscular specialist. Fastest path: Submit complete prior authorization with genetic test report, 6-minute walk test

Do You Qualify for Voxzogo (Vosoritide) Coverage by Aetna CVS Health in New Jersey? Complete Decision Tree & Appeals Guide

Answer Box: Voxzogo Coverage by Aetna CVS Health in New Jersey Who qualifies: Children with achondroplasia, open growth plates, and specialist prescription. Fastest path: Gather genetic testing (FGFR3 mutation), growth plate imaging, and baseline growth data. Submit PA through CVS Caremark at 1-800-294-5979. If denied: Use New Jersey's

How to Get Evrysdi (Risdiplam) Covered by UnitedHealthcare in New Jersey: Prior Authorization, Appeals, and Coding Guide

Answer Box: Getting Evrysdi Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Evrysdi (risdiplam) in New Jersey with specific documentation: genetic confirmation of 5q-linked SMA, baseline motor function scores, and neurologist consultation. If denied, you have 180 days to appeal internally, then 60 days for New Jersey&

The Requirements Checklist to Get Kuvan (Sapropterin) Covered by Blue Cross Blue Shield in New Jersey: Forms, Appeals, and Success Strategies

Answer Box: Getting Kuvan Covered by Blue Cross Blue Shield in New Jersey Eligibility: Patients with confirmed PKU and elevated phenylalanine levels (>360 µmol/L) can get Kuvan covered by Blue Cross Blue Shield in New Jersey through prior authorization. Fastest path: 1) Gather PKU diagnosis, recent labs, and

How to Get Symdeko/Symkevi Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization Guide

Answer Box: Getting Symdeko/Symkevi Covered by UnitedHealthcare in New Jersey Symdeko (tezacaftor/ivacaftor) requires prior authorization through UnitedHealthcare/OptumRx in New Jersey. Key requirements: CF specialist prescription, FDA-cleared genotype testing showing F508del mutation, documented diagnosis (ICD-10 E84.x), and age ≥6 years. The medication is Tier 5 (specialty) with

Aetna (CVS Health) Coverage Criteria for Therakos CELLEX Photopheresis in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Therakos CELLEX Covered by Aetna (CVS Health) in New Jersey Aetna (CVS Health) covers Therakos CELLEX photopheresis for cutaneous T-cell lymphoma (CTCL) and steroid-refractory graft-versus-host disease (GVHD) when specific medical necessity criteria are met. Your fastest path to approval: 1) Have your specialist (dermatologist, hematologist, or oncologist)

Work With Your Doctor to Get Rinvoq (upadacitinib) Approved by Blue Cross Blue Shield in New Jersey: Complete Provider Collaboration Guide

Answer Box: Getting Rinvoq Covered in New Jersey Blue Cross Blue Shield (BCBS) in New Jersey requires prior authorization for Rinvoq (upadacitinib) with strict step therapy requirements. You must typically try and fail TNF alpha biologics first. Success depends on close collaboration with your doctor to document medical necessity, prior